Trial Profile
Efficacy of the Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 23 Nov 2022 Status changed from recruiting to completed.
- 09 Oct 2020 Planned End Date changed from 1 Jun 2020 to 1 Jun 2023.
- 09 Oct 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2022.